{"id":"NCT00699751","sponsor":"Bayer","briefTitle":"A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases","officialTitle":"A Double-blind, Randomised, Multiple Dose, Phase III, Multicentre Study of Alpharadin in the Treatment of Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-06","primaryCompletion":"2011-07","completion":"2014-02","firstPosted":"2008-06-18","resultsPosted":"2014-05-07","lastUpdate":"2016-05-27"},"enrollment":921,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hormone Refractory Prostate Cancer","Bone Metastases"],"interventions":[{"type":"DRUG","name":"Radium-223 dichloride (Xofigo, BAY88-8223)","otherNames":["Alpharadin"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Best standard of care (BSoC)","otherNames":[]}],"arms":[{"label":"Radium-223 dichloride (Xofigo, BAY88-8223)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"ALSYMPCA (ALpharadin in SYMPtomatic Prostate CAncer) is an international Phase III clinical study to evaluate the efficacy and safety of Radium-223 dichloride in patients with hormone refractory prostate cancer and skeletal metastases.","primaryOutcome":{"measure":"Overall Survival","timeFrame":"From randomization to death due to any cause until approximately 3 years after start of enrollment, the data was collected up to the second data analysis date (15 JUL 2011)","effectByArm":[{"arm":"Radium-223 Dichloride (Xofigo, BAY88-8223)","deltaMin":14.9,"sd":null},{"arm":"Placebo","deltaMin":11.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.00005"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":134,"countries":["United States","Australia","Belgium","Brazil","Canada","Czechia","France","Germany","Hong Kong","Israel","Italy","Netherlands","Norway","Poland","Singapore","Slovakia","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["23863050","25439694","24836273","25840395","25832684","24857093","24775727","24610703","24052017","23977665","27930924"],"seeAlso":["http://www.clinicaltrialsregister.eu/"]},"adverseEventsSummary":{"seriousAny":{"events":286},"commonTop":["Bone pain","Nausea","Anaemia","Fatigue","Diarrhoea"]}}